nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—Abdominal discomfort—Cladribine—multiple sclerosis	0.0102	0.0285	CcSEcCtD
Papaverine—Abdominal discomfort—Azathioprine—multiple sclerosis	0.00833	0.0232	CcSEcCtD
Papaverine—Diarrhoea—Fingolimod—multiple sclerosis	0.00733	0.0204	CcSEcCtD
Papaverine—Ill-defined disorder—Cladribine—multiple sclerosis	0.00691	0.0192	CcSEcCtD
Papaverine—Headache—Fingolimod—multiple sclerosis	0.00671	0.0187	CcSEcCtD
Papaverine—Malaise—Cladribine—multiple sclerosis	0.00671	0.0187	CcSEcCtD
Papaverine—Discomfort—Cladribine—multiple sclerosis	0.00626	0.0174	CcSEcCtD
Papaverine—Anorexia—Cladribine—multiple sclerosis	0.00579	0.0161	CcSEcCtD
Papaverine—Hepatitis—Mitoxantrone—multiple sclerosis	0.00562	0.0157	CcSEcCtD
Papaverine—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00561	0.0156	CcSEcCtD
Papaverine—Malaise—Azathioprine—multiple sclerosis	0.00546	0.0152	CcSEcCtD
Papaverine—Decreased appetite—Cladribine—multiple sclerosis	0.00528	0.0147	CcSEcCtD
Papaverine—Constipation—Cladribine—multiple sclerosis	0.00519	0.0145	CcSEcCtD
Papaverine—Discomfort—Azathioprine—multiple sclerosis	0.00509	0.0142	CcSEcCtD
Papaverine—Feeling abnormal—Cladribine—multiple sclerosis	0.00501	0.0139	CcSEcCtD
Papaverine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00454	0.0126	CcSEcCtD
Papaverine—Malaise—Mitoxantrone—multiple sclerosis	0.00441	0.0123	CcSEcCtD
Papaverine—Diarrhoea—Cladribine—multiple sclerosis	0.00416	0.0116	CcSEcCtD
Papaverine—Discomfort—Mitoxantrone—multiple sclerosis	0.00412	0.0115	CcSEcCtD
Papaverine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00407	0.0113	CcSEcCtD
Papaverine—Rash—Cladribine—multiple sclerosis	0.00383	0.0107	CcSEcCtD
Papaverine—Dermatitis—Cladribine—multiple sclerosis	0.00383	0.0107	CcSEcCtD
Papaverine—Anorexia—Mitoxantrone—multiple sclerosis	0.00381	0.0106	CcSEcCtD
Papaverine—Headache—Cladribine—multiple sclerosis	0.00381	0.0106	CcSEcCtD
Papaverine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00372	0.0104	CcSEcCtD
Papaverine—Malaise—Prednisolone—multiple sclerosis	0.00362	0.0101	CcSEcCtD
Papaverine—Nausea—Cladribine—multiple sclerosis	0.00361	0.01	CcSEcCtD
Papaverine—Vertigo—Prednisolone—multiple sclerosis	0.00361	0.01	CcSEcCtD
Papaverine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00347	0.00967	CcSEcCtD
Papaverine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00342	0.00954	CcSEcCtD
Papaverine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00342	0.00952	CcSEcCtD
Papaverine—Constipation—Mitoxantrone—multiple sclerosis	0.00341	0.00951	CcSEcCtD
Papaverine—Diarrhoea—Azathioprine—multiple sclerosis	0.00338	0.00941	CcSEcCtD
Papaverine—Discomfort—Prednisolone—multiple sclerosis	0.00338	0.0094	CcSEcCtD
Papaverine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00335	0.00934	CcSEcCtD
Papaverine—Malaise—Triamcinolone—multiple sclerosis	0.00333	0.00927	CcSEcCtD
Papaverine—Malaise—Methylprednisolone—multiple sclerosis	0.00332	0.00925	CcSEcCtD
Papaverine—Vertigo—Triamcinolone—multiple sclerosis	0.00332	0.00924	CcSEcCtD
Papaverine—Vertigo—Methylprednisolone—multiple sclerosis	0.00331	0.00922	CcSEcCtD
Papaverine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00329	0.00916	CcSEcCtD
Papaverine—Rash—Azathioprine—multiple sclerosis	0.00311	0.00867	CcSEcCtD
Papaverine—Dermatitis—Azathioprine—multiple sclerosis	0.00311	0.00867	CcSEcCtD
Papaverine—Flushing—Prednisone—multiple sclerosis	0.00311	0.00866	CcSEcCtD
Papaverine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00311	0.00865	CcSEcCtD
Papaverine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00311	0.00865	CcSEcCtD
Papaverine—Discomfort—Triamcinolone—multiple sclerosis	0.0031	0.00865	CcSEcCtD
Papaverine—Discomfort—Methylprednisolone—multiple sclerosis	0.0031	0.00863	CcSEcCtD
Papaverine—Headache—Azathioprine—multiple sclerosis	0.00309	0.00862	CcSEcCtD
Papaverine—Malaise—Betamethasone—multiple sclerosis	0.00302	0.00841	CcSEcCtD
Papaverine—Malaise—Dexamethasone—multiple sclerosis	0.00302	0.00841	CcSEcCtD
Papaverine—Vertigo—Betamethasone—multiple sclerosis	0.00301	0.00838	CcSEcCtD
Papaverine—Vertigo—Dexamethasone—multiple sclerosis	0.00301	0.00838	CcSEcCtD
Papaverine—Nausea—Azathioprine—multiple sclerosis	0.00293	0.00817	CcSEcCtD
Papaverine—Discomfort—Dexamethasone—multiple sclerosis	0.00282	0.00785	CcSEcCtD
Papaverine—Discomfort—Betamethasone—multiple sclerosis	0.00282	0.00785	CcSEcCtD
Papaverine—Hepatitis—Methotrexate—multiple sclerosis	0.0028	0.0078	CcSEcCtD
Papaverine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00273	0.00761	CcSEcCtD
Papaverine—Ill-defined disorder—Prednisone—multiple sclerosis	0.00271	0.00754	CcSEcCtD
Papaverine—Feeling abnormal—Prednisolone—multiple sclerosis	0.0027	0.00752	CcSEcCtD
Papaverine—Malaise—Prednisone—multiple sclerosis	0.00263	0.00733	CcSEcCtD
Papaverine—Vertigo—Prednisone—multiple sclerosis	0.00262	0.0073	CcSEcCtD
Papaverine—Anorexia—Betamethasone—multiple sclerosis	0.00261	0.00726	CcSEcCtD
Papaverine—Anorexia—Dexamethasone—multiple sclerosis	0.00261	0.00726	CcSEcCtD
Papaverine—Rash—Mitoxantrone—multiple sclerosis	0.00252	0.00701	CcSEcCtD
Papaverine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00252	0.00701	CcSEcCtD
Papaverine—Headache—Mitoxantrone—multiple sclerosis	0.0025	0.00697	CcSEcCtD
Papaverine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00248	0.00691	CcSEcCtD
Papaverine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00248	0.0069	CcSEcCtD
Papaverine—Discomfort—Prednisone—multiple sclerosis	0.00245	0.00683	CcSEcCtD
Papaverine—Decreased appetite—Betamethasone—multiple sclerosis	0.00238	0.00662	CcSEcCtD
Papaverine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00238	0.00662	CcSEcCtD
Papaverine—Nausea—Mitoxantrone—multiple sclerosis	0.00237	0.00661	CcSEcCtD
Papaverine—Anorexia—Prednisone—multiple sclerosis	0.00227	0.00632	CcSEcCtD
Papaverine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00226	0.0063	CcSEcCtD
Papaverine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00225	0.00627	CcSEcCtD
Papaverine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00225	0.00627	CcSEcCtD
Papaverine—Malaise—Methotrexate—multiple sclerosis	0.0022	0.00612	CcSEcCtD
Papaverine—Vertigo—Methotrexate—multiple sclerosis	0.00219	0.0061	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—GPR65—multiple sclerosis	0.00215	0.00341	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events—IL6—multiple sclerosis	0.00215	0.0034	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—GPR65—multiple sclerosis	0.00215	0.0034	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CCR2—multiple sclerosis	0.00215	0.0034	CbGpPWpGaD
Papaverine—PDE3B—IRS-related events triggered by IGF1R—IL6—multiple sclerosis	0.00213	0.00337	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LINGO1—multiple sclerosis	0.00208	0.00329	CbGpPWpGaD
Papaverine—PDE3B—Insulin receptor signalling cascade—IL6—multiple sclerosis	0.00207	0.00328	CbGpPWpGaD
Papaverine—PDE3B—IGF1R signaling cascade—IL6—multiple sclerosis	0.00207	0.00328	CbGpPWpGaD
Papaverine—Decreased appetite—Prednisone—multiple sclerosis	0.00207	0.00576	CcSEcCtD
Papaverine—Rash—Prednisolone—multiple sclerosis	0.00207	0.00575	CcSEcCtD
Papaverine—Dermatitis—Prednisolone—multiple sclerosis	0.00206	0.00575	CcSEcCtD
Papaverine—PDE4B—GPCR downstream signaling—CCR1—multiple sclerosis	0.00206	0.00326	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00206	0.00326	CbGpPWpGaD
Papaverine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00206	0.00573	CcSEcCtD
Papaverine—Headache—Prednisolone—multiple sclerosis	0.00205	0.00572	CcSEcCtD
Papaverine—Discomfort—Methotrexate—multiple sclerosis	0.00205	0.00571	CcSEcCtD
Papaverine—PDE3A—Hemostasis—ITGA4—multiple sclerosis	0.00205	0.00325	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—GPR65—multiple sclerosis	0.00204	0.00323	CbGpPWpGaD
Papaverine—Constipation—Prednisone—multiple sclerosis	0.00204	0.00567	CcSEcCtD
Papaverine—PDE3A—Hemostasis—IFNB1—multiple sclerosis	0.00203	0.00322	CbGpPWpGaD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—multiple sclerosis	0.00202	0.0032	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CNR1—multiple sclerosis	0.00198	0.00314	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TAGAP—multiple sclerosis	0.00198	0.00313	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LINGO1—multiple sclerosis	0.00197	0.00313	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL13—multiple sclerosis	0.00197	0.00312	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCR1—multiple sclerosis	0.00197	0.00312	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00196	0.00311	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL13—multiple sclerosis	0.00196	0.00311	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCR1—multiple sclerosis	0.00196	0.00311	CbGpPWpGaD
Papaverine—Feeling abnormal—Prednisone—multiple sclerosis	0.00196	0.00546	CcSEcCtD
Papaverine—Nausea—Prednisolone—multiple sclerosis	0.00195	0.00542	CcSEcCtD
Papaverine—Rash—Triamcinolone—multiple sclerosis	0.0019	0.00529	CcSEcCtD
Papaverine—Dermatitis—Triamcinolone—multiple sclerosis	0.0019	0.00529	CcSEcCtD
Papaverine—Anorexia—Methotrexate—multiple sclerosis	0.0019	0.00528	CcSEcCtD
Papaverine—Rash—Methylprednisolone—multiple sclerosis	0.0019	0.00528	CcSEcCtD
Papaverine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00189	0.00527	CcSEcCtD
Papaverine—Headache—Triamcinolone—multiple sclerosis	0.00189	0.00526	CcSEcCtD
Papaverine—Headache—Methylprednisolone—multiple sclerosis	0.00188	0.00524	CcSEcCtD
Papaverine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00187	0.00521	CcSEcCtD
Papaverine—Diarrhoea—Betamethasone—multiple sclerosis	0.00187	0.00521	CcSEcCtD
Papaverine—PDE4B—Signaling by GPCR—CXCL13—multiple sclerosis	0.00187	0.00296	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCR1—multiple sclerosis	0.00187	0.00296	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TAGAP—multiple sclerosis	0.0018	0.00285	CbGpPWpGaD
Papaverine—Nausea—Triamcinolone—multiple sclerosis	0.00179	0.00498	CcSEcCtD
Papaverine—Nausea—Methylprednisolone—multiple sclerosis	0.00179	0.00497	CcSEcCtD
Papaverine—PDE10A—Signaling by GPCR—CXCL10—multiple sclerosis	0.00178	0.00283	CbGpPWpGaD
Papaverine—Decreased appetite—Methotrexate—multiple sclerosis	0.00173	0.00482	CcSEcCtD
Papaverine—PDE3B—Signaling Pathways—S1PR1—multiple sclerosis	0.00173	0.00274	CbGpPWpGaD
Papaverine—Rash—Betamethasone—multiple sclerosis	0.00172	0.0048	CcSEcCtD
Papaverine—Rash—Dexamethasone—multiple sclerosis	0.00172	0.0048	CcSEcCtD
Papaverine—Dermatitis—Betamethasone—multiple sclerosis	0.00172	0.0048	CcSEcCtD
Papaverine—Dermatitis—Dexamethasone—multiple sclerosis	0.00172	0.0048	CcSEcCtD
Papaverine—PDE3B—Signaling by Insulin receptor—IL6—multiple sclerosis	0.00172	0.00273	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—ALB—multiple sclerosis	0.00172	0.00272	CbGpPWpGaD
Papaverine—Headache—Betamethasone—multiple sclerosis	0.00171	0.00477	CcSEcCtD
Papaverine—Headache—Dexamethasone—multiple sclerosis	0.00171	0.00477	CcSEcCtD
Papaverine—PDE4B—Signaling Pathways—TAGAP—multiple sclerosis	0.00171	0.00271	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—CCL5—multiple sclerosis	0.00169	0.00268	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GPC5—multiple sclerosis	0.00168	0.00266	CbGpPWpGaD
Papaverine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00164	0.00457	CcSEcCtD
Papaverine—Diarrhoea—Prednisone—multiple sclerosis	0.00163	0.00454	CcSEcCtD
Papaverine—PDE3B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00163	0.00258	CbGpPWpGaD
Papaverine—Nausea—Dexamethasone—multiple sclerosis	0.00162	0.00452	CcSEcCtD
Papaverine—Nausea—Betamethasone—multiple sclerosis	0.00162	0.00452	CcSEcCtD
Papaverine—PDE3A—Signaling Pathways—S1PR1—multiple sclerosis	0.00157	0.00249	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00157	0.00249	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—IL2RA—multiple sclerosis	0.00154	0.00243	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCL3—multiple sclerosis	0.00154	0.00243	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CCL5—multiple sclerosis	0.00154	0.00243	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GPC5—multiple sclerosis	0.00153	0.00242	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CCR2—multiple sclerosis	0.00153	0.00242	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—CCR5—multiple sclerosis	0.00152	0.00241	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.0015	0.00238	CbGpPWpGaD
Papaverine—Rash—Prednisone—multiple sclerosis	0.0015	0.00418	CcSEcCtD
Papaverine—Dermatitis—Prednisone—multiple sclerosis	0.0015	0.00418	CcSEcCtD
Papaverine—PDE4B—Signaling Pathways—S1PR1—multiple sclerosis	0.0015	0.00237	CbGpPWpGaD
Papaverine—Headache—Prednisone—multiple sclerosis	0.00149	0.00415	CcSEcCtD
Papaverine—PDE3A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00148	0.00235	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00148	0.00234	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RGS1—multiple sclerosis	0.00147	0.00233	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GPC5—multiple sclerosis	0.00146	0.00231	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00143	0.00227	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CXCR3—multiple sclerosis	0.00143	0.00226	CbGpPWpGaD
Papaverine—Nausea—Prednisone—multiple sclerosis	0.00141	0.00394	CcSEcCtD
Papaverine—PDE3B—GPCR downstream signaling—CNR1—multiple sclerosis	0.00141	0.00224	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00141	0.00223	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCL3—multiple sclerosis	0.0014	0.00222	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—IL2RA—multiple sclerosis	0.0014	0.00222	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCL3—multiple sclerosis	0.0014	0.00222	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CCR2—multiple sclerosis	0.00139	0.00221	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—IL2—multiple sclerosis	0.00139	0.00221	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GPR65—multiple sclerosis	0.00139	0.00221	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCR2—multiple sclerosis	0.00139	0.0022	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CCR5—multiple sclerosis	0.00138	0.00219	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL2RA—multiple sclerosis	0.00136	0.00216	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00136	0.00216	CbGpPWpGaD
Papaverine—Diarrhoea—Methotrexate—multiple sclerosis	0.00136	0.00379	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—PTGER4—multiple sclerosis	0.00135	0.00214	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PTGER4—multiple sclerosis	0.00135	0.00213	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RGS1—multiple sclerosis	0.00134	0.00212	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCL3—multiple sclerosis	0.00133	0.00211	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PGR—multiple sclerosis	0.00133	0.00211	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CCR2—multiple sclerosis	0.00133	0.0021	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCR3—multiple sclerosis	0.0013	0.00206	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCR3—multiple sclerosis	0.0013	0.00206	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CD28—multiple sclerosis	0.00129	0.00205	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CNR1—multiple sclerosis	0.00129	0.00204	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CNR1—multiple sclerosis	0.00128	0.00203	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00128	0.00203	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCR1—multiple sclerosis	0.00127	0.00202	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL13—multiple sclerosis	0.00127	0.00202	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RGS1—multiple sclerosis	0.00127	0.00202	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00127	0.00201	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GPR65—multiple sclerosis	0.00127	0.00201	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCR2—multiple sclerosis	0.00127	0.00201	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCR2—multiple sclerosis	0.00127	0.002	CbGpPWpGaD
Papaverine—Rash—Methotrexate—multiple sclerosis	0.00125	0.00349	CcSEcCtD
Papaverine—Dermatitis—Methotrexate—multiple sclerosis	0.00125	0.00349	CcSEcCtD
Papaverine—Headache—Methotrexate—multiple sclerosis	0.00125	0.00347	CcSEcCtD
Papaverine—PDE4B—Signaling by GPCR—CXCR3—multiple sclerosis	0.00124	0.00196	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CNR1—multiple sclerosis	0.00122	0.00194	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GPR65—multiple sclerosis	0.00121	0.00191	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCR2—multiple sclerosis	0.0012	0.00191	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—POMC—multiple sclerosis	0.00119	0.00189	CbGpPWpGaD
Papaverine—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	0.00118	0.00187	CbGpPWpGaD
Papaverine—Nausea—Methotrexate—multiple sclerosis	0.00118	0.00329	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—CNR1—multiple sclerosis	0.00117	0.00185	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CNR1—multiple sclerosis	0.00117	0.00185	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL13—multiple sclerosis	0.00116	0.00184	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCR1—multiple sclerosis	0.00116	0.00184	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00116	0.00183	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CXCL10—multiple sclerosis	0.00115	0.00183	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—ALB—multiple sclerosis	0.00111	0.00176	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CNR1—multiple sclerosis	0.00111	0.00176	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL13—multiple sclerosis	0.0011	0.00175	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCR1—multiple sclerosis	0.0011	0.00175	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0011	0.00174	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CCL5—multiple sclerosis	0.00109	0.00173	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—TGFB1—multiple sclerosis	0.00109	0.00172	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—POMC—multiple sclerosis	0.00108	0.00171	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—MAPK1—multiple sclerosis	0.00107	0.00169	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—CCL2—multiple sclerosis	0.00106	0.00168	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL10—multiple sclerosis	0.00105	0.00167	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL10—multiple sclerosis	0.00105	0.00167	CbGpPWpGaD
Papaverine—PDE10A—nervous system—multiple sclerosis	0.00103	0.108	CbGeAlD
Papaverine—PDE3A—Hemostasis—ALB—multiple sclerosis	0.00101	0.0016	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CXCL10—multiple sclerosis	0.001	0.00158	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000997	0.00158	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCL5—multiple sclerosis	0.000994	0.00157	CbGpPWpGaD
Papaverine—PDE10A—central nervous system—multiple sclerosis	0.000991	0.104	CbGeAlD
Papaverine—PDE3B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000986	0.00156	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000972	0.00154	CbGpPWpGaD
Papaverine—PDE10A—cerebellum—multiple sclerosis	0.000968	0.102	CbGeAlD
Papaverine—PDE10A—Signaling by GPCR—TYK2—multiple sclerosis	0.000961	0.00152	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000948	0.0015	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CD86—multiple sclerosis	0.000921	0.00146	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCL3—multiple sclerosis	0.000907	0.00144	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCL5—multiple sclerosis	0.000907	0.00144	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCL5—multiple sclerosis	0.000905	0.00143	CbGpPWpGaD
Papaverine—PDE3B—cerebellum—multiple sclerosis	0.000902	0.0946	CbGeAlD
Papaverine—PDE3B—Hemostasis—IL2—multiple sclerosis	0.000901	0.00143	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000898	0.00142	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCR5—multiple sclerosis	0.000895	0.00142	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000885	0.0014	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000882	0.0014	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—IL2—multiple sclerosis	0.00088	0.00139	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTGER4—multiple sclerosis	0.000873	0.00138	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCL5—multiple sclerosis	0.000861	0.00136	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PGR—multiple sclerosis	0.00086	0.00136	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000854	0.00135	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCR3—multiple sclerosis	0.000844	0.00134	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000842	0.00133	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SPP1—multiple sclerosis	0.00084	0.00133	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CD28—multiple sclerosis	0.000836	0.00132	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL3—multiple sclerosis	0.000826	0.00131	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—IL2—multiple sclerosis	0.000821	0.0013	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCR2—multiple sclerosis	0.000821	0.0013	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCR5—multiple sclerosis	0.000817	0.00129	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCR5—multiple sclerosis	0.000815	0.00129	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2RA—multiple sclerosis	0.000805	0.00128	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000804	0.00127	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL2—multiple sclerosis	0.000799	0.00127	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTGER4—multiple sclerosis	0.000796	0.00126	CbGpPWpGaD
Papaverine—PDE10A—brain—multiple sclerosis	0.000787	0.0825	CbGeAlD
Papaverine—PDE4B—Signaling Pathways—CCL3—multiple sclerosis	0.000786	0.00124	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PGR—multiple sclerosis	0.000783	0.00124	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCR5—multiple sclerosis	0.000776	0.00123	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—POMC—multiple sclerosis	0.00077	0.00122	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCR3—multiple sclerosis	0.000768	0.00122	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000764	0.00121	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD28—multiple sclerosis	0.000761	0.00121	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CNR1—multiple sclerosis	0.000757	0.0012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTGER4—multiple sclerosis	0.000757	0.0012	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCR2—multiple sclerosis	0.000747	0.00118	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PGR—multiple sclerosis	0.000745	0.00118	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—APOE—multiple sclerosis	0.000743	0.00118	CbGpPWpGaD
Papaverine—PDE3B—brain—multiple sclerosis	0.000733	0.0769	CbGeAlD
Papaverine—PDE4B—Signaling Pathways—CXCR3—multiple sclerosis	0.000731	0.00116	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD28—multiple sclerosis	0.000724	0.00115	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCR2—multiple sclerosis	0.000711	0.00113	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TGFB1—multiple sclerosis	0.000703	0.00111	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—POMC—multiple sclerosis	0.000702	0.00111	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—POMC—multiple sclerosis	0.0007	0.00111	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CNR1—multiple sclerosis	0.00069	0.00109	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—MAPK1—multiple sclerosis	0.000689	0.00109	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCL2—multiple sclerosis	0.000685	0.00108	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL10—multiple sclerosis	0.000682	0.00108	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CD80—multiple sclerosis	0.000672	0.00106	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—POMC—multiple sclerosis	0.000667	0.00106	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CNR1—multiple sclerosis	0.000656	0.00104	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TGFB1—multiple sclerosis	0.00064	0.00101	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—POMC—multiple sclerosis	0.000639	0.00101	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—POMC—multiple sclerosis	0.000637	0.00101	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—MAPK1—multiple sclerosis	0.000628	0.000994	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCL2—multiple sclerosis	0.000625	0.00099	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCL2—multiple sclerosis	0.000623	0.000987	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—TYK2—multiple sclerosis	0.000622	0.000984	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL10—multiple sclerosis	0.000621	0.000984	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000611	0.000968	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—POMC—multiple sclerosis	0.000606	0.00096	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CD86—multiple sclerosis	0.000596	0.000944	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCL2—multiple sclerosis	0.000593	0.000939	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL10—multiple sclerosis	0.000591	0.000936	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCL5—multiple sclerosis	0.000587	0.00093	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—IL2—multiple sclerosis	0.00057	0.000902	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TYK2—multiple sclerosis	0.000567	0.000899	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—TYK2—multiple sclerosis	0.000566	0.000897	CbGpPWpGaD
Papaverine—PDE4B—medulla oblongata—multiple sclerosis	0.000562	0.0589	CbGeAlD
Papaverine—PDE3A—cerebellum—multiple sclerosis	0.000551	0.0578	CbGeAlD
Papaverine—PDE3B—Signaling Pathways—SPP1—multiple sclerosis	0.000544	0.000861	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD86—multiple sclerosis	0.000543	0.00086	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—TYK2—multiple sclerosis	0.000539	0.000853	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL5—multiple sclerosis	0.000535	0.000847	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCR5—multiple sclerosis	0.000529	0.000838	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2RA—multiple sclerosis	0.000521	0.000825	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2—multiple sclerosis	0.000519	0.000822	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2—multiple sclerosis	0.000517	0.000819	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD86—multiple sclerosis	0.000517	0.000818	CbGpPWpGaD
Papaverine—PDE4B—midbrain—multiple sclerosis	0.000514	0.0539	CbGeAlD
Papaverine—PDE4B—Signaling Pathways—CCL5—multiple sclerosis	0.000509	0.000805	CbGpPWpGaD
Papaverine—PDE4B—spinal cord—multiple sclerosis	0.000501	0.0526	CbGeAlD
Papaverine—PDE3A—Signaling Pathways—SPP1—multiple sclerosis	0.000495	0.000784	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2—multiple sclerosis	0.000493	0.000781	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCR5—multiple sclerosis	0.000482	0.000763	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APOE—multiple sclerosis	0.000481	0.000762	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2RA—multiple sclerosis	0.000475	0.000752	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2—multiple sclerosis	0.000472	0.000748	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2—multiple sclerosis	0.000471	0.000746	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SPP1—multiple sclerosis	0.000471	0.000746	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—multiple sclerosis	0.00047	0.000744	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCR5—multiple sclerosis	0.000458	0.000726	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2RA—multiple sclerosis	0.000452	0.000715	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2—multiple sclerosis	0.000448	0.00071	CbGpPWpGaD
Papaverine—PDE3A—brain—multiple sclerosis	0.000448	0.047	CbGeAlD
Papaverine—PDE10A—Signaling Pathways—MMP9—multiple sclerosis	0.000447	0.000708	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APOE—multiple sclerosis	0.000438	0.000694	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CD80—multiple sclerosis	0.000435	0.000689	CbGpPWpGaD
Papaverine—PDE4B—nervous system—multiple sclerosis	0.000422	0.0443	CbGeAlD
Papaverine—PDE4B—Signaling Pathways—APOE—multiple sclerosis	0.000417	0.00066	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—POMC—multiple sclerosis	0.000413	0.000655	CbGpPWpGaD
Papaverine—PDE4B—central nervous system—multiple sclerosis	0.000407	0.0426	CbGeAlD
Papaverine—PDE3B—Signaling Pathways—CCL2—multiple sclerosis	0.000404	0.00064	CbGpPWpGaD
Papaverine—PDE4B—cerebellum—multiple sclerosis	0.000397	0.0417	CbGeAlD
Papaverine—PDE10A—Signaling Pathways—STAT3—multiple sclerosis	0.000397	0.000629	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CD80—multiple sclerosis	0.000396	0.000627	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000396	0.000627	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CD80—multiple sclerosis	0.000377	0.000597	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—POMC—multiple sclerosis	0.000376	0.000596	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—multiple sclerosis	0.000369	0.000585	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TGFB1—multiple sclerosis	0.000368	0.000583	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL2—multiple sclerosis	0.000368	0.000583	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TYK2—multiple sclerosis	0.000367	0.000582	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK1—multiple sclerosis	0.000361	0.000572	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAPK1—multiple sclerosis	0.00036	0.000571	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—POMC—multiple sclerosis	0.000358	0.000567	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCL2—multiple sclerosis	0.00035	0.000555	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000343	0.000543	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TYK2—multiple sclerosis	0.000334	0.00053	CbGpPWpGaD
Papaverine—PDE4B—brain—multiple sclerosis	0.000323	0.0339	CbGeAlD
Papaverine—PDE4B—Signaling Pathways—TYK2—multiple sclerosis	0.000318	0.000504	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2—multiple sclerosis	0.000306	0.000484	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—multiple sclerosis	0.000304	0.000481	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP9—multiple sclerosis	0.000289	0.000458	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2—multiple sclerosis	0.000278	0.000441	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—multiple sclerosis	0.000278	0.00044	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—multiple sclerosis	0.000277	0.000439	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2—multiple sclerosis	0.000265	0.000419	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP9—multiple sclerosis	0.000263	0.000417	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—multiple sclerosis	0.000263	0.000417	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STAT3—multiple sclerosis	0.000257	0.000407	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP9—multiple sclerosis	0.000251	0.000397	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—multiple sclerosis	0.000239	0.000378	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFB1—multiple sclerosis	0.000238	0.000377	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STAT3—multiple sclerosis	0.000234	0.000371	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK1—multiple sclerosis	0.000234	0.00037	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT3—multiple sclerosis	0.000223	0.000353	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—multiple sclerosis	0.000218	0.000345	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFB1—multiple sclerosis	0.000217	0.000344	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK1—multiple sclerosis	0.000213	0.000337	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—multiple sclerosis	0.000207	0.000328	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFB1—multiple sclerosis	0.000206	0.000327	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK1—multiple sclerosis	0.000202	0.000321	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—multiple sclerosis	0.00018	0.000284	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—multiple sclerosis	0.000164	0.000259	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—multiple sclerosis	0.000156	0.000246	CbGpPWpGaD
